Patents Assigned to MODULATION THERAPEUTICS
  • Cyclic peptide conjugates and methods of use
    Patent number: 10011635
    Abstract: The present invention concerns cyclic compounds, compositions comprising the cyclic compounds, linkers, a method of preparing a carrying agent:cyclic compound adduct, a method for treating disorders such as proliferation disorders (e.g., malignancies), bone deficiency diseases, and autoimmune diseases, and a method for suppressing the growth of, or inducing apoptosis in, cells (e.g., malignant cells).
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: July 3, 2018
    Assignees: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., UNIVERSITY OF SOUTH FLORIDA, MODULATION THERAPEUTICS, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Lori Hazlehurst, Christoph Rader, Xiuling Li, Mark McLaughlin